-
公开(公告)号：US20240181002A1
公开(公告)日：2024-06-06
申请号：US18515599
申请日：2023-11-21
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K38/168 , A61P3/04 , A61K2236/19 , A61K2236/333 , A61K2236/37
Abstract: The present disclosure relates to a composition for anti-obesity including a green tea peptide composition. Specifically, the green tea peptide composition according to the one aspect of the present disclosure exhibits anti-obesity efficacy through excellent lipid metabolism activation and can be applied to various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20240189386A1
公开(公告)日：2024-06-13
申请号：US18515425
申请日：2023-11-21
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K38/168 , A61K36/82 , A61K38/08 , A61K38/10 , A61P19/00 , A61K2236/19 , A61K2236/333 , A61K2236/39
Abstract: The present disclosure relates to a composition for anti-fatigue comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure exhibits anti-fatigue efficacy through excellent effects of inhibiting production of fatigue substances within a muscle cell, increasing ATP production within the muscle cell, and promoting fat oxidation within the muscle cell, and can be applied to various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20240390320A1
公开(公告)日：2024-11-28
申请号：US18663736
申请日：2024-05-14
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Wanki KIM , Jong Hwa ROH
IPC: A61K31/353 , A61K31/7048 , A61P3/04
Abstract: Disclosed herein is a method for inhibiting lipogenesis; inhibiting fat accumulation; promoting fat breakdown; reducing body fat; and/or preventing, improving or treating obesity or metabolic diseases. In one aspect, Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) of the present invention have excellent lipid metabolism control effects, can increase mitochondria in adipocytes, and promote the production of brown fat. Therefore, in one aspect, the present invention can provide a method for preventing, improving, or treating obesity or metabolic diseases.
-
4.发明公开公开(公告)号：US20230372417A1
公开(公告)日：2023-11-23
申请号：US18313465
申请日：2023-05-08
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Donghyun CHO , Wanki KIM , Jong Hwa ROH
IPC: A61K35/747 , A23L33/135 , A61P1/16
CPC classification number: A61K35/747 , A23L33/135 , A61P1/16 , A23Y2220/67
Abstract: A method for improving hepatic function, including administering an effective amount of a composition including a green tea-derived Lactiplantibacillus plantarum strain; a culture of the strain; a lysate of the strain; an extract of the strain; an extract of the culture; or an extract of the lysate to a subject in need thereof is disclosed in the specification.
-
Patent Agency Ranking
5.发明公开公开(公告)号：US20240226223A1
公开(公告)日：2024-07-11
申请号：US18536404
申请日：2023-12-12
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
CPC classification number: A61K36/82 , A61K38/168 , A61P21/00 , A61K2236/19 , A61K2236/331 , A61K2236/333
Abstract: The present disclosure relates to a composition for preventing, improving, or treating muscle loss comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure may exhibit an efficacy in preventing, improving, or treating muscle loss through the excellent effects of increasing protein synthesis in muscle cells and inhibiting protein degradation in the muscle cells, and thus may be applied in various health functional food compositions and pharmaceutical compositions.
-
公开(公告)号：US20230381262A1
公开(公告)日：2023-11-30
申请号：US18325484
申请日：2023-05-30
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Woo JEONG , Jinoh CHUNG , Wanki KIM , Jong Hwa ROH
IPC: A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/00
CPC classification number: A61K36/82 , A61P29/00 , A23L33/105 , A23L2/52 , A23L33/40
Abstract: A method for reducing absorption of a microplastic in a body, including administering a composition including an effective amount of a green tea extract to a subject in need thereof is disclosed in the specification. One aspect of the present disclosure is the composition may be a food composition or a pharmaceutical composition.
-
公开(公告)号：US20230095813A1
公开(公告)日：2023-03-30
申请号：US17935949
申请日：2022-09-28
Applicant: AMOREPACIFIC CORPORATION
Inventor： Changyong MOON , Su Hwan KIM , Jihae LEE , Kyoungmi JUNG , Wonkyung CHO , Wanki KIM , Jong Hwa ROH , Chan WOONG PARK
IPC: A61K31/197 , A61K31/198 , A61K31/455 , A61P25/00 , A61K9/20 , A61K9/48 , A61K9/14 , A61K9/16 , A61K9/00 , A23L33/15 , A23L33/175
Abstract: The present disclosure relates to a composition for improving sleep quality, including γ-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof. The composition for improving sleep quality may improve the sleep quality by increasing melatonin secretion. In addition, in another aspect, the present disclosure provides a composition for alleviating stress, including γ-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof.
-
公开(公告)号：US20220000775A1
公开(公告)日：2022-01-06
申请号：US17289382
申请日：2019-10-16
Applicant: Amorepacific Corporation
Inventor： Wonkyung CHO , Kwanghyun SHIN , Joonho CHOI , Kiwha LEE , Jong Hwa ROH , Miyoung PARK , Youngho PARK , Eunsil PARK , Jaehong PARK , Byoung Young WOO , Min Soo KIM , Eun Sol HA
Abstract: One aspect of the present disclosure relates to a sol-gel composition enabling reversible sol-gel transition and, more specifically, to a sol-gel composition of which the viscosity changes by external physical force so that reversible sol-gel transition is performed.
-
![PHARMACEUTICAL COMPOSITION CONTAINING (R)-N-[1-(3,5-DIFLUORO-4-METHANSULFONYLAMINO-PHENYL)-ETHYL]-3-(2-PROPYL-6-TRIFLUOROMETHYL-PYRIDIN-3-YL)-ACRYLAMIDE](/abs-image/US/2020/07/09/US20200215040A1/abs.jpg.150x150.jpg)
公开(公告)号：US20200215040A1
公开(公告)日：2020-07-09
申请号：US16638038
申请日：2018-08-10
Applicant: AMOREPACIFIC CORPORATION
Inventor： Joon Ho CHOI , Won Kyung CHO , Kwang-Hyun SHIN , Byoung Young WOO , Ki-Wha LEE , Min-Soo KIM , Jong Hwa ROH , Mi Young PARK , Young-Ho PARK , Eun Sil PARK , Jae Hong PARK
Abstract: One aspect of the present disclosure is a pharmaceutical composition which includes (R)—N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of one aspect of the present disclosure has a formulation characteristic in which crystal formation is delayed for a long time.
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.012 seconds)
